Not the right time: Why parents refuse to let their daughters have the human papillomavirus vaccination

Acta Paediatrica, International Journal of Paediatrics

Volumn 103, Issue 4, 2014, Pages 436-441

  Grandahl, Maria ^a   Oscarsson, Marie ^a,b   Stenhammar, Christina ^a   Nevéus, Tryggve ^c   Westerling, Ragnar ^a   Tydén, Tanja ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b LINNAEUS UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Decision making; Human papillomavirus; Parents; School; Vaccination programmes

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGE; ARTICLE; DAUGHTER; FEMALE; HUMAN; INTERVIEW; MALE; MASS IMMUNIZATION; NARCOLEPSY; NORMAL HUMAN; PAPILLOMAVIRUS INFECTION; PARENTAL ATTITUDE; PARENTING EDUCATION; PATIENT DECISION MAKING; PRIORITY JOURNAL; QUALITATIVE RESEARCH; SWEDEN; TREATMENT REFUSAL; TRUST; VACCINATION; WART VIRUS VACCINATION;

EID: 84896123340     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12545     Document Type: Article

References (30)

1. LaMontagne DS, Barge S, Le NT, Mugisha E, Penny ME, Gandhi S, et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ 2011; 89: 821-30B.
2. Lu B, Kumar A, Castellsague X, Giuliano AR,. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis 2011; 11: 13.
3. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine 2012; 30 (Suppl 5): F12-23.
4. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
5. Bosch FX, Tsu V, Vorsters A, Van Damme P, Kane MA,. Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases. Vaccine 2012; 30 (Suppl 5): F1-11.
6. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007; 369: 2161-70.
7. Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, et al. Human papillomavirus vaccine introduction-the first five years. Vaccine 2012; 30 (Suppl 5): F139-48.
8. Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J, et al. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surveill 2010; 15: pii: 19730.
9. Sheridan A, White J, Barlow T, Soldan K,. Annual HPV vaccine uptake in England: 2008/09 London, UK: Department of Health, 2010.
10. Laz TH, Rahman M, Berenson AB,. An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010. Vaccine 2012; 30: 3534-40.
11. Previous Human Papilloma Virus (HPV) Immunisation Uptake Rates. ISD Scotland/ National Health Services Scotland; 2009 [cited 2012 June 11]; Available from: http://www.isdscotland.org/Health-Topics/Child-Health/ Immunisation/HPV-Archive.asp. (accessed on June 11, 2012).
12. Gilmour J, Harrison C, Asadi L, Cohen MH, Vohra S,. Childhood immunization: when physicians and parents disagree. Pediatrics 2011; 128 (Suppl 4): S167-74.
13. Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, Kitchener H, et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 2008; 336: 1056-8.
14. Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med 2010; 7: e1000270.
15. Swedish Institute for Communicable Disease Control [Smittskyddsinstitutet]. Statistics for HPV vaccinations. 2013 [cited 2013 08 Feb]; Available from: http://www.smittskyddsinstitutet.se/nyhetsarkiv/2013/stor- andel-flickor-vaccinerade-sig-mot-hpv/. (accessed on February 08, 2013)
16. Burnard P, Gill P, Stewart K, Treasure E, Chadwick B,. Analysing and presenting qualitative data. Br Dent J 2008; 204: 429-32.
17. Kane MA,. Global implementation of human papillomavirus (HPV) vaccine: lessons from hepatitis B vaccine. Gynecol Oncol 2010; 117 (2 Suppl): S32-5.
18. Salmon DA, Sotir MJ, Pan WK, Berg JL, Omer SB, Stokley S, et al. Parental vaccine refusal in Wisconsin: a case-control study. WMJ 2009; 108: 17-23.
19. Dawson A,. The determination of 'best interests' in relation to childhood vaccinations. Bioethics 2005; 19: 188-205.
20. Schwartz JL, Caplan AL,. Ethics of vaccination programs. Current Opin Virol 2011; 1: 263-7.
21. Dawson A,. The moral case for the routine vaccination of children in developed and developing countries. Health Aff 2011; 30: 1029-33.
22. Harrell H,. Currents in contemporary ethics: HPV vaccines, privacy, and public health. J Law Med Ethics 2009; 37: 134-8.
23. Verweij M, Dawson A,. Ethical principles for collective immunisation programmes. Vaccine 2004; 22: 3122-6.
24. Medical Products Agency. Questions and answers about narcolepsy after vaccination with Pandemrix.: Medical Products Agency [Läkemedelsverket]; 2012 [cited 2013 07 June]; Available from: http://www.lakemedelsverket.se/ OVRIGA-SIDOR/Den-nya-influensan-H1N1/Fragor-och-svar-om-narkolepsi-efter- pandemivaccination/. (accessed on June 7, 2013).
25. Allen JD, Othus MK, Shelton RC, Li Y, Norman N, Tom L, et al. Parental decision making about the HPV vaccine. Cancer Epidemiol Biomarkers Prev 2010; 19: 2187-98.
26. Dempsey AF, Abraham LM, Dalton V, Ruffin M,. Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 2009; 19: 531-8.
27. Gottvall M, Grandahl M, Hoglund AT, Larsson M, Stenhammar C, Andrae B, et al. Trust versus concerns-how parents reason when they accept HPV vaccination for their young daughter. Ups J Med Sci 2013; 118: 263-70.
28. Grandahl M, Tyden T, Gottvall M, Westerling R, Oscarsson M,. Immigrant women's experiences and views on the prevention of cervical cancer: a qualitative study. Health Expect 2012; doi: 10.1111/hex.12034 [Epub ahead of print].
29. Griffioen AM, Glynn S, Mullins TK, Zimet GD, Rosenthal SL, Fortenberry JD, et al. Perspectives on decision making about human papillomavirus vaccination among 11- to 12-year-old girls and their mothers. Clin Pediatr 2012; 51: 560-8.
30. Gefenaite G, Smit M, Nijman HW, Tami A, Drijfhout IH, Pascal A, et al. Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands: Insights from a behavioral survey among parents. BMC Public Health 2012; 12: 498.